Danish Pharmacovigilance Update, 19 January 2012

In this issue of Danish Pharmacovigilance Update:

• Patients treated with statins at risk of developing diabetes, front page
• Proton-pump inhibitors (PPI) and risk of hypomagnesaemia with long-term use, front page
• New Nordic study confirms a causal relationship between treatment with antidepressants of the SSRI type and increased risk of persistent pulmonary hypertension of the newborn (PPHN), page 2
• Study of Rasilez® and Rasilez® HCT (aliskiren) was stopped early and has now triggered a review of efficacy and safety, page 3
• Risk of depression from gonatropin-releasing hormone (GnRH) agonists, page 4
• No evidence for increased risk of mortality in children treated with the growth hormone somatropin, page 4
• Progressive multifocal leukoencephalopathy (PML) in connection with Tysabri® (natalizumab), page 5
• Assessment of Articain® – an anaesthetic in dental treatment, page 5

Download the newsletter in the box to the right.